Search Results - "Battafarano, G."

Mechanisms of acute hypercalcemia in pediatric patients following the interruption of Denosumab by Deodati, A., Fintini, D., Levtchenko, E., Rossi, M., Ubertini, G., Segers, H., Battafarano, G., Cappa, M., Del Fattore, A.

“…Purpose Denosumab is a fully human monoclonal anti-RANK-L antibody that is clinically used to counteract the bone loss induced by exacerbated osteoclast…”
Get full text

Analysis of circulating osteoclast and osteogenic precursors in patients with Gorham-Stout disease by Rossi, M., Terreri, S., Battafarano, G., Rana, I., Buonuomo, P. S., Di Giuseppe, L., D’Agostini, M., Porzio, O., Di Gregorio, J., Cipriani, Cristiana, Jenkner, A., Gonfiantini, M. V., Bartuli, A., Del Fattore, A.

“…Purpose Gorham-Stout disease is a very rare disorder characterized by progressive bone erosion and angiomatous proliferation; its etiopathogenesis is still…”
Get full text

The Role of Extracellular Vesicles in Bone Metastasis by Rossi, Michela, Battafarano, Giulia, D'Agostini, Matteo, Del Fattore, Andrea

“…Multiple types of cancer have the specific ability to home to the bone microenvironment and cause metastatic lesions. Despite being the focus of intense…”
Get full text

A 3D-Printed Multi-Chamber Device Allows Culturing Cells On Buckypapers Coated With PAMAM Dendrimer And Obtain Innovative Materials For Biomedical Applications by Paolini, Alessandro, Battafarano, Giulia, D'Oria, Valentina, Mura, Francesco, Sennato, Simona, Mussi, Valentina, Risoluti, Roberta, Materazzi, Stefano, Del Fattore, Andrea, Masotti, Andrea

“…The advent of 3D printing technology allowed the realization of custom devices that can be used not only in the everyday life but also in the nanotechnology…”
Get full text

PB1649 EXOSOMES‐MEDIATED DELIVERY OF RNA OLIGOS DIRECTED TO CHE‐1/AATF IMPAIRS BCP‐ALL VITALITY by Caforio, M., Sorino, C., Bertaina, V., Pitisci, A., Battafarano, G., Del Fattore, A., Fanciulli, M., Folgiero, V., Locatelli, F.

“…Background: Precursor B cell acute lymphoblastic leukemia (BCP‐ALL) is the most common childhood malignancy and represents the leading cause of cancer‐related…”
Get full text